WEST PHARMACEUTICAL SERVICES INC. 2024-2025 Proxy Voting Records

Description as filed by funds: Election of Directors: Deborah L. V. Keller

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Deborah L. V. Keller”): 55,149,806 for, 7,367,368 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 24,518,689 for, 2,722,848 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Douglas A. Michels

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Douglas A. Michels”): 59,815,698 for, 2,962,814 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 26,755,124 for, 486,413 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Eric M. Green

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Eric M. Green”): 57,172,136 for, 5,326,139 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 26,767,613 for, 473,924 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Janet B. Haugen

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Janet B. Haugen”): 60,548,312 for, 2,279,202 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 27,241,486 for, 51 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Mark A. Buthman

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Mark A. Buthman”): 61,532,802 for, 1,245,670 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 27,205,840 for, 25,763 against, 11,760 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Molly E. Joseph

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Molly E. Joseph”): 62,289,941 for, 530,576 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 27,229,816 for, 1,787 against, 11,760 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Myla P. Lai-Goldman

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Myla P. Lai-Goldman”): 61,584,879 for, 1,254,542 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 27,209,239 for, 32,298 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Paolo Pucci

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Paolo Pucci”): 61,243,782 for, 1,534,344 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 26,781,831 for, 459,706 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Robert F. Friel

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Robert F. Friel”): 61,263,541 for, 1,514,601 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 26,781,831 for, 459,706 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Stephen H. Lockhart

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Stephen H. Lockhart”): 62,513,899 for, 264,308 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 27,241,486 for, 51 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: Thomas W. Hofmann

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Thomas W. Hofmann”): 58,015,309 for, 4,679,404 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 27,166,809 for, 74,728 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Election of Directors: William F. Feehery

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: William F. Feehery”): 60,733,034 for, 2,055,576 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 155 asset managers below reported 27,214,046 for, 27,491 against, 1,826 abstained.

Showing the 25 largest of 155 asset managers. See all 155 in the interactive database.

Description as filed by funds: Amend and Restate Our Amended and Restated Articles of Incorporation to Add a Right For Shareholders to call a Special Meeting;

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 3: Our shareholders approved an amendment and restatement of our Articles of Incorporation to add a right for shareholders to call a special meeting by the following vote:”): 62,707,017 for, 88,400 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Our shareholders approved an amendment and restatement of our Articles of Incorporation to add a right for shareholders to call a special meeting by the following vote:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 27,211,628 for, 29,983 against, 1,826 abstained.

Showing the 25 largest of 156 asset managers. See all 156 in the interactive database.

Description as filed by funds: Amend and Restate Our 2016 Omnibus Incentive Compensation Plan; and

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 4: Our shareholders approved the amendment and restatement of our 2016 Omnibus Incentive Compensation Plan by the following vote:”): 60,862,053 for, 1,883,395 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4: Our shareholders approved the amendment and restatement of our 2016 Omnibus Incentive Compensation Plan by the following vote:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 170 asset managers below reported 26,800,817 for, 496,268 against, 1,826 abstained.

Showing the 25 largest of 170 asset managers. See all 170 in the interactive database.

Description as filed by funds: Advisory vote to approve named executive officer compensation.

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:”): 59,222,338 for, 3,516,476 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 154 managers: 26,751,846 for, 471,230 against, 1,826 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 588 managers: 38,308,518 for, 2,717,428 against, 6,699 abstained, 9,811 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm FOR 2025.

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year by the following vote:”): 60,537,221 for, 4,373,036 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year by the following vote:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 153 asset managers below reported 27,121,058 for, 105,494 against, 1,826 abstained.

Showing the 25 largest of 153 asset managers. See all 153 in the interactive database.